The expression of the metabotropic glutamate receptor mGluR1 was studied with Northern and Western blot analysis, with immunocytochemistry, and with Ca2+ digital imaging in the developing rat hypothalamus. mGluR1 is coupled to a G protein and activation by glutamate and related agonists leads to intracellular phosphotidylinositol hydrolysis and Ca*+ mobilization.
mGluR1 RNA could be detected in embryonic hypothalamus, and by the day of birth and prior to the primary period of synaptogenesis, both mGluR1 RNA and protein were strongly expressed.
In parallel experiments with digital imaging of cultured hypothalamic cells, some embryonic day 18 hypothalamic neurons and many astrocytes after 3 d in vitro showed Ca*+ responses to quisqualate and t-ACPD, and to glutamate in the absence of extracellular Ca*+. A greater number of embryonic neurons responded to NMDA than to agonists of the metabotropic receptor. With increased development time in culture, the number of neurons that responded to metabotropic glutamate receptor agonists increased.
In the adult hypothalamus, mGluR1 -immunoreactive neurons were widespread, and particularly dense in the dorsomedial, lateral, and anterior hypothalamus/preoptic areas, and in the mammillary body. Strongly immunoreactive cells were interspersed among neurons with no immunoreactivity. In developing neurons a diffuse immunostaining appeared along dendrites and somata. With time, beginning in the first week after birth, strongly stained puncta appeared, possibly associated with synaptic specializations. These puncta were numerous on dendrites of some adult neurons, and were the most strongly stained regions of neurons. Neurons developing in vitro at low neuron densities showed a development of mGluR1 immunoreactivitysimilarto that of neurons in vivo, but with a delayed progression of immunostaining. We found no obvious staining of axons or of astrocytes.
A strong expression of mGluR1 protein was found in the hypothalamus during the first 2 postnatal weeks; this expression was partially reduced in adults. In contrast, cerebellum showed no reduction in niGluR1 protein in adults. Together these data suggest a complex regulation of mGluR1 during development, with sufficient expression of functional receptors in the developing hypothalamus to modulate morphogenesis and synaptogenesis, and later to play a role in transduction of glutamate signals in the adult. Different regions of the brain showed dramatic differences in the way each expresses mGluR1 during development.
[Key words: calcium, neuroendocrine, suprachiasmatic nucleus, paraventricular nucleus, q&qua/ate, t-ACPD, NMDA, astrocytes] Glutamate receptors can be divided into two general groups, the ionotropic group which includes the AMPA, kainate, and NMDA-type receptors that open cation channels, and the metabotropic receptors that activate second messenger systems via a G protein. Activation of the metabotropic receptor leads to increases in phosphotidylinositol (PI) hydrolysis, resulting in formation of diacylglycerol and IP, and mobilization of Ca2+ from intracellular stores (Furuya et al., 1989) ; these second messengers modulate a wide variety of enzymatic pathways, gene expression, and cellular growth and differentiation (Mayer and Miller, 1990; Schoepp et al., 1990; Shigemoto et al., 1992; Yuzaki and Mikoshiba, 1992) . Stimulation of mGluR1 has also been reported to induce the formation of CAMP and the release of arachidonic acid (Aramori and Nakanishi, 1992; Fotuhi et al., 1992) . A number of genes coding for both ionotropic (Sugiyama et al., 1987; Hollmann et al., 1989; Moriyoshi et al., 1991) and metabotropic (Houamed et al., 1991; Masu et al., 199 1; Abe et al., 1992; Tanabe et al., 1992) glutamate receptors have been cloned. During development these glutamate receptors may be expressed prior to substantial synapse formation and may play a role in influencing the organization of the developing brain. A growing body of evidence indicates that glutamate may be released early in development (LoTurco et al., 199 1) and may modulate neuronal structure and connections (Mattson et al., 1988; Cline and Constantine-Paton, 1990; Constantine-Paton et al., 199 1) .
In preliminary work we found a strong expression of the mGluR 1 metabotropic receptor in the hypothalamus in the developing rat brain. Previous functional studies have suggested that the hypothalamic metabotropic receptor is extremely active in the neonatal brain in inducing PI hydrolysis, but that it is almost inactive in the adult brain (Palmer et al., 1990; Sortino et al., 199 l) , making the hypothalamus a useful model for studying developmental regulation of the metabotropic receptor. Parallel developmental studies in some, but not all, regions of the brain have demonstrated a similar elevated functional activity ofthe metabotropic receptor in neonatal neurons compared with adult neurons (Nicoletti et al., 1986; Guiramand et al., 1989; Palmer et al., 1990; Balduini et al., 199 1; Boss et al., 1992) . One hypothesis for the strong neonatal functional activation of the metabotropic receptor is the presence of large numbers of receptors during that time period that subsequently diminish with age (Guiramand et al., 1989) .
Within the hypothalamus glutamate appears to play an important role as a primary excitatory neurotransmitter. High levels of glutamate are found in hypothalamic presynaptic boutons by ultrastructural immunocytochemistry (Meeker et al., 1989; van den Pol, 199 1) . In previous work we have demonstrated with intracellular recording in adult slices (van den Pol et al., 1990) and with patch-clamp recording of pairs of developing synaptically coupled neurons in vitro (van den Pol and Trombley, 1993 ) that glutamate may be the major excitatory transmitter of the medial hypothalamus. We have also shown with in situ hybridization and Northern blots that both the NMDA and non-NMDA ionotropic glutamate receptor genes are expressed throughout the adult hypothalamus (van den Pol et al., 1994) . That functional glutamate receptors are expressed in hypothalamic neurons is supported by electrophysiology (Arnauld et al., 1983; Swandulla and Misgeld, 1990) , Ca2+ imaging studies (van den Pol et al., 1990 (van den Pol et al., , 1992 ) and neuroendocrine perturbation studies (Brann and Mahesh, 1992) .
To study the developmental regulation of the metabotropic glutamate receptor mGluR1, which is widely expressed in the developing and adult CNS, we examined the mRNA levels with Northern blots and the protein levels with Western blots at different stages of hypothalamic development. This particular receptor is interesting developmentally because of its role in modulation of intracellular Ca2+ (Nakanishi, 1992) and the ability of glutamate agonists to alter mGluR1 RNA levels in developing neurons (Bessho et al., 1993) . Other brain regions including the hippocampus and cerebellum were used for comparative examination of mGluR levels. To study the change in the metabotropic receptor expression at the cellular level, we immunostained a series of brains from embryo, neonate, and adult rats, with a focus on the hypothalamus where the distribution of metabotropic receptors has not been examined previously. Immunostaining was done in parallel on developing neurons in culture. To assess the functional activity of the metabotropic glutamate receptor in developing hypothalamic neurons, we used Ca2+ digital imaging of cultured hypothalamic cells.
An abstract of some of this work has been presented (van den Pol et al., 1993) .
Materials and Methods
Immunocytochemisty. Postnatal day 1 (Pl), PI, P2 1, and adult SpragueDawley rats were anesthetized with hypothermia and/or Nembutal and perfused transcardially with cold 0.1 M phosphate-buffered 0.9% saline (PBS), followed by 4% paraformaldehyde prepared in 0.1 M PBS. Fourteen neonatal and 12 adult brains were dissected out and allowed to fix in 4% paraformaldehyde for at least 24 hr before sectioning. Four embryonic day 18 (E 18) brains were fixed in 1% acrolein for 2 hr and then in 4% paraformaldehyde overnight. The brains of animals younger than Pl were cut into 30 Frn sections using a cryostat. These brains were cryoprotected in 15% and then 30% sucrose for 25 hr prior to cutting. Sections were either suspended in washing buffer or thaw mounted on gelatin-coated slides heated to 45°C and then dried for 15 min before washing. The rest of the procedure was identical to that used for the sections cut from older animals. The brains of older animals were cut into 30-50 pm sections using a Vibratome.
Slices were washed in 0.1 M phosphate buffer containing 1% bovine serum albumin (BSA), 0.1% Tris, 0.1% lysine, and 0.4% Triton X-100.
Slices were blocked in washing buffer with 2% normal goat serum for at least 30 min and were then incubated in primary antibody at 10°C for 2 to 3 d. Rabbit anti-mGluRla antibodies (Martin et al., 1992) or GluR2/3 antibodies (Blackstone et al., 1992a) used as controls were diluted up to 1: 1000 in blocking buffer containing 0.0 1% sodium azide to prevent contamination during the incubation period. Slices were washed a second time before the l-2 hr incubation in secondary antibody, biotinylated goat anti-rabbit IgG. For histochemical staining, sections were washed and then incubated in the avidin and biotinylated horseradish peroxidase macromolecular complex (Vectastain Elite ABC Kit) in blocking buffer for 30 min. Sections were then rinsed twice in washing buffer and once in 0.1 M Tris buffer, pH 7.2, and then reacted with 3,3'-diaminobenzidine
(1 mg/ml) in the presence of hydrogen peroxide. Sections were then treated with 0.1% osmium tetroxide to enhance contrast of the immunoreactive neurons, dehydrated, and coverslipped.
The mGluRla antibodies were generated against a peptide (KPNVTYASVILRDYKQSSSTL) corresponding to the C-terminal 20 amino acids (residues 1180-l 199) ofthe predicted polypeptide sequence encoded bv the mGluR1oc cDNA in rat brain (Houamed et al.. 1991 : Masu et ai., 1991 Tanabe et al., 1992) . An N-terminal lysine residue was added to the peptide to facilitate coupling of the peptide to the carrier protein. Antisera against carrier protein-conjugated peptides were raised in New Zealand White rabbits. The mGluRla antiserum used in the present study was affinity purified on a column of BSA-conjugated mGluR 10~ ueotide bound to Affi-Gel 15 (Bio-Rad). The antibodies have been charac&zed previously, and bind specifically to the mGluR1 protein on Western blots of synaptosomal membranes (Blackstone et al., 1992a; Martin et al., 1992) . Adsorption controls in which the synthetic peptide (1 O-50 FM) was incubated with the antibodies prior to their use blocked immunostaining on sections, in culture, and on Westem blots.
Of all known metabotropic glutamate receptors, mGluR5 is the most similar to mGluRla. Even so, the C-terminus of the mGluR5 protein shares only a 50% (10 of 20) amino acid identity with the mGluRlol peptide used for antibody production (Abe et al., 1992) . The general pattern of immunostaining with the mGluRlu antibody (Martin et al., 1992) resembles much more closely the mRNA distribution of mGluR 1 than mGluR5 (Abe et al., 1992) . Finally, regions high in mGluR5, such as striatum, show little immunoreactivity using this antibody preparation. Thus, it seems likely that cross-reactivity with mGluR5, if any, is minimal. No cross-reactivity with other metabotropic glutamate receptors has been found, and would not be expected given the lack of similarity of the amino acid sequence used for antibody generation here and the known sequences of other cloned metabotropic receptors (Tanabe et al., 1992) . The mGluR1oc antibody used in the present study would not recognize mGluR1 b or mGluRlc (Pin et al., 1992) . Given the lack of homology between metabotropic and ionotropic glutamate receptors, no cross-reactivity of the antiserum used in the present study with ionotropic receptors would be expected.
Northern blots-RNA. Total cellular RNA was obtained from brain tissue by extraction in guanidinium thiocyanate followed by overnight sedimentation of total RNA through a cesium chloride cushion, phenolchloroform extraction and, finally, ethanol precipitation of the resulting pellet after dissolving in buffer containing 10 mM Tris 7.5, 1 mM EDTA, 0.3 M sodium acetate, and 0.2% SDS. Three brains were removed for each age.
Samples (10 fig) of total RNA were electrophoresed on 1% agarose, 2.2 M formaldehyde gels in MOPS buffer. RNA was transferred by blotting to nylon filters (Nytran, Schleicher and Schuell) overnight in 10 x sodium-citrate/sodium chloride (SSC). Following baking at 80°C for 2 hr, filters were hybridized at 42°C overnight in 50% deionized formamide, 10% dextran sulfate, 1 M NaCl, 1% SDS, and 150 wg/ml denatured salmon sperm DNA. A 3.5 kb insert from the pmGR1 metabotropic glutamate receptor plasmid (a generous gift of Dr. S. Nakanishi) was obtained by digestion with EcoRI and XbaI restriction enzymes and subsequent isolation and purification. A rat 1 kb actin probe cut with PstI and XbaI was used as a control for RNA loading on the gel. Probes were labeled with 32P-dCTP by the random hexamer primer extension method (Feinberg and Vogelstein, 1983) usually to specific activities of 2.5-5 x lo* cpm/ml, and subsequently used at 3-4 x lo6 The greatest expression is in the cerebellum. After stripping the blot, the blot was probed a second time for y-actin, shown at the bottom. The consistent size and density of the actin bands confirms that similar amounts of RNA were loaded in each lane. Molecular weights (7.4 and 4.4 kb) are shown by arrowheads (see Fig. 11 for further description). Multiple bands on Northern blots have been reported before with mGluR1 (Houamed et al., 1991; Masu et al., 1992; Bessho et al., 1993) , and may represent alternatively spliced forms of mGluR 1 (Houamed et al., 199 1; Abe et al., 1992; Pin et al., 1992) . The higher-molecular-weight band likely represents mGluRlor, and the lower may represent mGluR1 b and/or mGluRlc. cpm/ml in the hybridization mix. Following hybridization, filters were washed successively with 2 x SSC for 5 min at room temperature (three times); 2x SSC, 1% SDS for 30 to 45 min at 65°C (two times); and 0.2x SSC, 0.1% SDS for 30 to 45 min at 65°C (two times).
Western blots-protein. Whole brains and defined brain regions were dissected from 15 Sprague-Dawley rats of different ages and immediately frozen on dry ice. The tissues were stored at -80°C until use. Protein extracts were prepared by individually homogenizing each tissue sample in a small precooled mortar and pestle maintained in dry ice throughout the procedure. Pulverized tissue was suspended in several hundred microliters of a modified buffer (Blackstone et al., 1992b) containing 20 mM Tris-HCl (pH 7.4), 10% sucrose, and 0.1 mM PMSF as a protease inhibitor, and vortexed three times for 1 min with 1 min cooling intervals on ice. The samples were subsequently centrifuged for 10 min at 14,000 rpm in an Eppendorfcentrifuge, and the resulting supematant quick-frozen in aliquots as the working crude extract. The final protein concentration was about 10 mg/ml, and the extracts were stable through repeated freezethaw cycles. Coomassie-stained SDS-polyacrylamide gels were routinely used to judge the concentration and quality of the extracts.
Western blots were carried out using 8% SDS-polyacrylamide gels run on a minigel apparatus (Hoefer); about 30 wg of protein was loaded per lane. Samples were heated at 37°C for 1 hr before adding the loading dye. The gels were transferred to nitrocellulose by electroblotting for 1 hr (100 V), and the filter blocked for 24 hr at 4°C in 0.5% nonfat dry milk and 0.1% Tween. Blots were then incubated with mGluR1 antibodies at a 1: 1000 dilution in 10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween for 2 hr, washed three times for 10 min in the same buffer, and incubated for 1 hr with horseradish peroxidase-conjugated donkey antirabbit immunoglobulin G (Amersham) diluted to 1: 1000 in phosphatebuffered saline containing 0.1% Tween 20 and 5% nonfat dry milk. The blots were subsequently washed four times for 20 min in the same buffer, The highest levels of mGluR1 protein were found in the cerebellum, followed by the olfactory bulb, and then by hypothalamus, hippocampus, and forebrain. Liver showed no specific label for mGluR1, but a slight crossreactivity of the antibodies with a lower-molecular-weight protein could be detected. Arrow indicates the origin at the top of the gel. Molecular weight was determined with prestained high-molecular-weight SDS-PAGE standards (Bio-Rad).
followed by four 20 min washes in phosphate-buffered saline minus the milk. Immunoreactive proteins were revealed using enhanced chemiluminescence (ECL, Amersham). Western blots were run in duplicate or triplicate with similar results.
Tissue culture. The hypothalami were dissected from 102 El8 rats, disaggregated in the presence of papain as describe 1 previously (van den Pol et al., 1992) , and plated on polylysine (M! 560,000)-coated 22 mm square sterile glass coverslips. Cultures were I zintained in vitro for 3 & 1 d before use for digital imaging.
Some cultures (n = 90) were used for Ca2+ imagin and others (n = 12) were used for immunocytochemistry.
Immune lining was performed in a manner similar to that used to stain bra sections.
Calcium digital imaging. Cultured cells were washed ge..tly with HEPES buffer, and then loaded with flu03 acetoxymethyl ester. Among known Ca2+ indicator dyes, flu03 is the most sensitive, and is therefore optimally useful for the detection of minimal Ca2+ responses expected in embryonic cells after short times in culture. Cells were placed in a flowthrough chamber (Forscher et al., 1987) with a volume of about 185 ~1 that could be serially perfused with glutamate agonists and antagonists. The chamber was placed on a Nikon inverted microscope fitted with an Optiquip 150 W xenon light source and a Sutter filter wheel and shutter assembly under computer control. Video frames were recorded on a Panasonic 2023 analog laser disk recorder at 1 or 2 set intervals. Each recorded frame was the average of eight single video frames, gathered with an Image I Fluor system (Universal Imaging). To reduce phototoxicity and photobleaching, 95% of the light emitted by the light source was blocked with neutral density filters; a computer-controlled shutter was closed during the intervals when frames were not being averaged. A Hamamatsu C2400 silicon intensified target (SIT) camera was used to capture video images.
Flu03 calcium data are presented as the change in fluorescence over the baseline fluorescence for each cell @F/F,). This provides correction for differential dye loading, potential heterogeneity in the video field, and variations in video gain and offset. The equations that this is based on are described in detail elsewhere (Cornell-Bell et al., 1990; van den Pol et al., 1990; Finkbeiner, 1991 Finkbeiner, , 1992 .
The HEPES buffer used was as described before (Cornell-Bell et al., 1990; van den Pol et al., 1990) , and contained 10 mM HEPES, 25 mM glucose, 1 mM MgCI,, 2.5 mM CaCl,, and 137 mM NaCl. To reduce the magnesium blockade of the NMDA receptor, experiments with NMDA were done in the absence of MgCl, with the addition of 2 PM glycine. In experiments done with zero calcium, the HEPES buffer had no calcium, but did contain 3 mM EGTA. This neuron shows small immunoreactive puncta, most clearly seen on the dendrites (arrows), but also detectable on the perikaryon (double arrowhead). Scale bar, 10 Frn.
Among these regions, the strongest mGluR1 mRNA expression was found in the olfactory bulb and cerebellum, with adult cerebellum the strongest. The hypothalamus also showed a clear expression of mGluR1 mRNA, slightly greater than that found in the hippocampus (Fig. 1) .
Examination of mGluR1 protein in different brain regions with Western blots showed the receptor to be strongly expressed in the cerebellum and olfactory bulb of the adult brain (Fig. 2) . The protein expression in the hypothalamus was greater than in the hippocampus, similar to the RNA results. The whole brain showed strong mGluR1 protein expression, in part due to the robust expression of cerebellum and olfactory bulb, which were included in this sample. Liver, used as a negative control, showed no specific expression of mGluR 1. Adult brain: immunocytochemistry mGluR1 immunoreactivity was found throughout the medial and lateral (Fig. 3A) parts of the adult hypothalamus. The immunoreactive neurons extended from the rostra1 preoptic area back to the mammillary body. In some regions strong immunoreactivity was found, and in others the immunoreactivity was very weak. In most regions of the hypothalamus, immunoreactive cells were interspersed with neurons showing no detectable labeling (Fig. 3A) . The number of immunoreactive cells varied in different regions of the hypothalamus; some regions had fewer than 1% labeled cells, and others, for instance the mammillary body, had labeling so dense that it appeared that the majority of cells were immunoreactive.
At the cellular level, the strongest staining was associated with small densities on the plasma membrane of perikarya (Fig. 4) , proximal dendrites (Fig. 4) , distal dendrites (Fig. 5 ) and sometimes on dendritic spines (Fig. 3B) . Immunolabeling was found out to the ends of long dendrites reaching several hundred micrometers from the perikaryon of origin, and strong staining could be found on both distal and proximal dendrites (Fig. 5) . The densities were from 0.5 pm to 2 pm in diameter, and strongly suggestive of a synaptic localization. No clear evidence of axonal labeling was found. A light diffuse staining was found in the cytoplasm of dendrites and cell bodies of immunoreactive cells.
In the medial hypothalamus immunolabeling was found throughout the suprachiasmatic nuclei (SCN). The staining density was so diffuse within the nucleus that it was difficult to differentiate stained cells from cells that may not have been immunoreactive. Immunoreactive cells were found in the dorsal rim of the optic chiasm ventral to the SCN, and dendrites of these cells reached up into the SCN. Immunolabeled dendrites were found between the paired SCN. Little mGluR1 staining was found in the magnocellular neurons of the paraventricular (Fig. 6A,B) and supraoptic nuclei; weak labeling was found in the medial parvicellular paraventricular nuclei. The ventral paraventricular nucleus did show immunoreactive cells and dendrites. Similar to the neurosecretory neurons of the paraventricular nucleus, the arcuate nucleus did not show very strong immunoreactivity. Ventral to the arcuate nucleus, the median eminence, which is composed primarily of tuberoinfundibular axons, showed no labeling (Fig. 60) . Immunoreactivity was weak in the ventromedial nucleus despite the presence of long dendrites from immunoreactive cells in the regions lateral and dorsolateral to it that reached into the nucleus. The dorsomedial region of the hypothalamus showed interspersed neurons with long dendritic arbors that were immunoreactive. A strong net of dendritic arbors extended from the dorsomedial hypothalamus into the lateral hypothalamus.
The fornix and mammillothalamic tracts were surrounded by immunoreactive cells and their dendrites. Immunoreactive dendrites from nearby neurons reached into these regions, but the axons of the tracts were not labeled (Fig. 3) . Similarly, axons of the optic tract were not labeled (Fig. 3A) .
Immunoreactive cells were dispersed throughout the preoptic area and anterior hypothalamus. Many immunoreactive cells were found in the medial preoptic area adjacent to the third ventricle and in the lateral preoptic area. Labeling was not found in the axons of the anterior commissure.
Caudally, the mammillary nuclei appeared strongly immunoreactive, with an intensity greater than rostra1 regions of the hypothalamus. This was due in large part to the large number of immunoreactive neurons and in part to the strong immunoreactivity in individual cells.
Developing brain: immunocytochemistry Light immunoreactivity
was found in the developing brain as early as day El& the earliest time point we studied. Single differentiated cells did not stand out as they did in older animals, but some regions of the brain showed immunoreactivity, particularly an area extending down from the highly reactive globus pallidus into the lateral preoptic area.
Immunoreactivity was found in developing neurons throughout the brain by P 1. Particularly striking in the medial hypothalamus was the labeling found in the SCN. Labeling was also found in the other regions that showed immunoreactivity in the adult brain. Many neurons at this early stage of development showed a morphology typical of immature neurons, and the labeling of these cells was weak. On the other hand, some neurons were strongly immunoreactive even on distal dendrites (Fig. 7A,B) . Little indication of synaptic labeling was found at this stage. Rather, the immunoreactivity was more diffuse along the plasma membrane, compared to the punctate staining that was more often found in older animals.
In P7 and P9 developing brains, staining began to parallel that seen in the adult. For instance, the SCN appeared strongly labeled at all postnatal stages examined, including Pl, P7, P9, P21, and adult. Similarly, the mammillary body began to express mGluR 1 at P 1 and this immunoreactivity increased with age. The primary change with development was the intensity and definition of labeling on single cells that appeared to increase in more mature neurons. In contrast to the SCN, the paraventricular and supraoptic nuclei consistently showed only weak labeling throughout hypothalamic development. At P7 and P9, discrete punctate regions of immunoreactivity on the plasmalemma started to appear (Fig. 7C,D) . During the next 2 weeks these puncta became more numerous and the relative staining intensity increased. As in adults, these punctate densities had the appearance of being associated with synaptic specializations, as suggested in other parts of the brain with electron microscopic analyses (Martin et al., 1992) .
Although we find a decrease in mGluR1 protein levels with Western blots, this is less obvious with immunocytochemistry. The decrease in protein observed in blots may be due to a decrease in the number of cells expressing the receptor, or to a decrease in cytoplasmic receptor; neither of these decreases would necessarily be detected with immunocytochemical staining. While we cannot readily compare staining intensity with immunoperoxidase at different ages, we do observe some relative decreases in immunoreactivity in some hypothalamic regions. For instance, in the early neonatal rat the suprachiasmatic nucleus is strongly immunoreactive compared with the lateral hypothalamus on the same section. On the other hand, in adults the staining in the suprachiasmatic nucleus is relatively weak in comparison to the immunoreactive neurons of the lateral hypothalamus. The number of immunoreactive perikarya in thick vibratome sections of the hypothalamus is often obscured by strong staining on high densities of dendrites, making it difficult to assess the number of immunostained cells at different developmental ages.
Neurons developing in vitro: immunoreactivity Hypothalamic cells from E 18 embryos were grown in vitro and immunostained at several intervals. After 7 d in vitro (DIV) a small number of cells showed strong immunoreactivity. The soma (Fig. 84 ) and the dendrites (Fig. 8.4 ,B) of immunoreactive neurons were stained. The staining in general appeared diffuse. Strong staining of astrocytes was not found. By 12 DIV the staining appeared slightly more intense (Fig. 8C) . Immunoreactivity on the dendrites was found to the terminal ends of dendrites (Fig. 8C) . Presumptive axons were either not labeled (Fig. 8E) or only the proximal part of the axon was labeled, and the intensity of staining decreased and then disappeared with distance from the axon hillock (Fig. 80) . By 22 DIV, punctate staining of dendrites was found (Fig. 9A) . On some neurons (Fig.  9B ) immunoreactive spines and dendritic appendages were found; other neurons had smooth immunoreactive dendrites lacking spines (Fig. 9C) . Incubation of the antibody with the peptide antigen blocked neuronal immunostaining (Fig. 9D ).
Immunocytochemical controls
To address the question of antibody specificity, we omitted the primary antiserum and found no staining. When we substituted another primary antiserum we obtained a different pattern of staining, both at the regional level and the cellular level. For instance, use of an antibody against the AMPA (a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid) glutamate receptors that bound selectively to both GluR2 and GluR3 subunits (Blackstone et al., 1992a) gave very different patterns of staining, including a more cytoplasmic appearance in hypothalamic cells. When the mGluR1 antibody was preadsorbed with the peptide Figure 8 . mGluR1 immunoreactivity in hypothalamic neurons in vitro: 7 and 12 DIV. A, After 7 DIV, soma and dendrites are stained. B, Immunoreactive dendrites were lightly stained at their terminal ends. C, At 12 DIV dendrites and the somata of reactive cells were stained. D, Some axons showed a slight reactivity proximally (single arrow) that diminished and was lost distally (double arrow). E, Immunoreactivity on other axons (double arrow) was not detected. Scale bars: A, 13 pm; B, 3 pm; C, 20 pm; D, 11 pm; E, 16 Nrn. Northern blots of whole brain RNA extracts were compared at different stages of development (Fig. 10) . A very slight hybrids sZ;rE ization with the mGluR1 probe was detected at El5 that was clearly seen by El 8. This increased at Pl and was very strong __ ' by P 14. Only a slight increase from P 14 to P30 was found. Actin ,,\ '_ controls used to check on gel loading showed that, if anything, \ _ __, ,__ less RNA was loaded from older animals, thus confirming the _' _i \ general relative increase in mGluR 1 expression. Different regions .
_' of the brain were studied in a time series analysis of Northern 7.4 KB b \ ,',' blots ( Fig. 11) . At all ages, including Pl, PlO, P20, and adults, the cerebellum showed the strongest RNA expression, and the 4.4 KB b ._ ' "', olfactory bulb also showed a strong expression. Faint bands at the expected size for mGluR1 (7.4 kb) were seen as early as El 8 in hypothalamus, olfactory bulb, and cortex. By Pl strong bands were found in all regions studied at 7.4 and 4.4 kb, similar to : '> \, the two bands reported by Masu et al. (199 1) (Fig. 12A) .
To examine the expression of mGluR1 protein in discrete brain regions, particularly in the hypothalamus in comparison to other regions including the hippocampus and cerebellum, protein extracted from E18, Pl, P9, P1.5, and adult was compared (Fig. 12B) . The intensity of the mGluR1 band was strongest in the cerebellum at all times tested, and showed a gradual \ increase from Pl to adult. At early stages of development, the \ hypothalamus showed a greater expression of mGluR 1 protein than the hippocampus. In the hypothalamus a gradual increase Figure 10 . Developmental series of whole brain: Northern blot. A slight band indicating mGluR 1 RNA is seen at E 15 at 7.4 kb, which increases in intensity through E18, Pl, P14, and P30. Controls with y-actin probes after stripping the blot show a slight decrease in RNA from the left to the right, indicating a decreased loading in successive lanes, suggesting that the relative developmental increase in mGluR1 is even greater than demonstrated in the blot above. Molecular weight markers (7.4 and 4.4 kb) are indicated by arrowheads.
antigen, immunostaining was blocked throughout the hypothalamus, hippocampus, and striatum; parallel immunostaining with the antibody at the same dilution on adjacent serial sections of the same brain was positive, as expected. One exception to the total loss of staining was in the SCN, where a faint reactivity was found after antigen adsorption; a similar light reactivity was seen in the substantia nigra after antigen adsorption. We interpret this to suggest that both areas do express mGluR1, but that they may in addition express some other antigen that crossreacts with the antibodies used. Previous Western blots showed a specific staining of a band at 142 kDa in synaptosomal preparations (Blackstone et al., 1992a; Martin et al., 1992) . The Western blots in the present study were done with whole brain tissue that included both synaptosomal and cytosolic fractions. The strong staining of the 142 kDa band ofthese whole brain extracts lends further support to the specificity of the affinity-purified antibodies used. in mGluR 1 was found, with expression detectable at E 18 and increasing at P7-P 15. In adult brains a slight decrease in mGluR1 relative to total protein was found in hypothalamus in comparison with younger brains.
Calcium imaging
In Western and Northern blots, little mGluR 1 RNA or protein is detectable at embryonic ages. To address the question of functional maturity of the metabotropic glutamate receptor in young developing neurons from embryonic brains, and to establish that the receptor in these immature neurons is actively coupled with G protein such that a Ca2+ response can be elicited by receptor activation, we examined hypothalamic cultures taken from El8 embryos and kept in vitro for 2-4 d (Fig. 13) . We found that these cells (95%+, n > 300) responded to glutamate with an increase in intracellular Ca*+. Increases in Ca*+ in these experiments could be due to activation of the NMDA receptor, some of the AMPA receptors (Hollmann et al., 1991; Hume et al., 1991; Verdoorn et al., 199 l) , or to metabotropic receptors (Furuya et al., 1989) .
Acute exposure of cultured cells to the nonselective metabotropic glutamate receptor agonist quisqualate (10 PM) increased intracellular Ca*+ in both neurons and astrocytes (Fig.  14) . Of 163 cells,..102 neurons responded to NMDA. Of these, a response to quisqualate was detected in 10 neurons. Of 66 cells with a morphology typical of astrocytes, 5 1 responded to Figure   12 . Developmental regulation of mGluR1: Western blot. A, During development a modest expression of mGluR1 protein was found in whole brain at PI; this increased dramatically by PlO and PI 5. Expression in adult whole brain was slightly greater than at the other ages. B, To follow the mGluR1 expression in selected brain regions, we compared hypothalamus with hippocampus and cerebellum. Lanes are shown in a developmental grouping, with the age indicated at the top. Little detectable mGluR1 protein was found at E18, but a slight reactivity was found at Pl, particularly in the cerebellum, and less in the hypothalamus. By P9 stronger labeling was seen in all three regions, with the greatest signal in the cerebellum. An increase in staining was found in the hypothalamic and cerebellar bands at P15. However, in adults, the hypothalamic and hippocampal bands were less intense than those seen in neonatal ages, whereas the cerebellum band showed the strongest intensity of any age.
These experiments were run in duplicate with relatively similar results found in each run. The arrowhead represents 142 kDa, and the arrow at the top of the blot shows the origin.
quisqualate and none responded to NMDA. Because quisqual- (Fig. 15) . Astrocytes (8 of 20) in the same culture dish also ate may activate ionotropic glutamate receptors in addition to responded to t-ACPD, but none responded to NMDA. To demmetabotropic receptors, we used the weaker but more selective onstrate that the cells that responded were neurons and not other metabotropic receptor agonist t-ACPD @runs-1 -amino-cyclotypes of cells, we stimulated the cells with NMDA. Only cells pentyl-1,3-dicarboxylic acid). About 20% of the total cells (11 with a morphology typical of cultured neurons responded to of 50) including glia and neurons responded to application of NMDA. Fewer astrocytes responded to t-ACPD than to quist-ACPD. Three of 30 neurons responded to 100 KM t-ACPD qualate. To determine if a longer duration in culture would increase the number of neurons that responded to metabotropic glutamate receptor agonists, we examined El 8 hypothalamic neurons after 5 or 6 d in culture. Of 55 neurons that responded to NMDA, 14 (2 1%) of these also responded to application of t-ACPD. Of the 55 neurons, 37 (67%) responded to quisqualate. If the percentage of neurons that responded at earlier times is compared with the number that responded at a later time in culture, the number ofcells that responded to t-ACPD doubled. The number of cells that responded to quisqualate increase by almost a factor of7.
The ionotropic receptors increase intracellular Ca2+ by opening channels in the external plasma membrane. In contrast, an increase in intracellular Ca2'-in the absence of extracellular Ca2+ must originate from intracellular stores. Such release has been characterized after activation of metabotropic glutamate receptors that stimulate phospholipase C, resulting in IP, production. Stimulation of El 8 neurons after 3 d in culture with glutamate (100 Km) in the absence of extracellular Ca2+ produced an increase in intracellular Ca'+ in two of 41 neurons that also responded to NMDA in the presence of extracellular Ca2+ (Fig.  16 ). Since neurons respond to NMDA and astrocytes do not, those cells that respond both to NMDA (in the presence of extracellular Ca*+) and to glutamate (in the absence of extracellular Ca'+ ) are neurons that express both ionotropic NMDA and metabotropic glutamate receptors. Ten additional cells had the general appearance of neurons, but did not respond to NMDA. Of 27 cells with the appearance of astrocytes, 21 responded to glutamate in the absence of extracellular Ca2+ (Fig.  16 ).
Discussion
Two related aspects of the glutamate metabotropic receptor mGluR1 are explored here. In the first, we examine the widespread but heterogeneous expression of the receptor throughout the hypothalamus. Having demonstrated mGluR1 in the hypothalamus, we then explore the complex developmental regulation of this receptor, examining RNA levels as a window on gene expression, investigating protein expression to study the distribution of the translated message, and studying the Ca2+ response with digital imaging to determine the functional maturity of the receptor in developing neurons.
Hypothalamic expression of mGluR1
In the adult hypothalamus, widespread expression of mGluR 1 was found, with levels similar to or greater than those in the hippocampus, a region of the brain more traditionally associated with glutamate neurotransmission. Based on immunocytochemistry, the high levels of mGluR1 in the mammillary body and lateral regions of the hypothalamus contributed a large part of the total. The mediobasal region showed the weakest expression of mGluR1 within the hypothalamus, both in adults and in the developing brain. Together with previous work demonstrating the expression of the NMDA, kainate, and AMPA receptor subtypes (van den Pol et al., in press ), the present study supports the general concept that glutamate plays a complex role in hypothalamic regulation. In addition to the diverse physiological actions of each of the individual ionotropic and metabotropic glutamate receptors, the metabotropic receptor may interact with and regulate glutamate (and GABA) ionotropic receptors in some regions of the brain (Glaum and Miller, 1993 Figure   14 . Ca2+ response of hypothalamic neurons to quisqualate. Two neurons (A and B), identified by their response to a 10 set application of 100 PM NMDA, also respond to 10 KM quisqualate. Astrocytes (C and D) also respond to quisqualate with an increase in intracellular Ca2+. Data are graphed as the change in fluorescence over baseline fluorescence (AFIF) , shown by the vertical calibration, and time in seconds, by the horizontalcalibration (Cornell-Bell et al., 1990; Finkbeiner, 199 1, 1992) . A delay of about 6 set occurs between the time the agonists are changed and when they reach the cells in the perfusion chamber.
ceptor activation may reduce phosphotidylinositol hydrolysis induced by the metabotropic glutamate receptor (Palmer et al., 1990) . The metabotropic receptor has been reported to decrease ionotropic receptor-mediated excitotoxicity in the retina (Sili- Figure 15 . Ca'+ response of hypothalamic neurons to t-ACPD. Neurons A and C show a Ca2+ increase in response to 100 PM t-ACPD. At this concentration t-ACPD should not activate ionotropic receptors (Shoepp et al., 1990) . Upon changing the buffer to one free of Mg2', an increase in fluorescence is found. That these cells are neurons is supported by the increase in Ca2+ in response to 100 FM NMDA. A similar modest response to 100 PM t-ACPD is found when the order of agonist perfusion is reversed, as seen in neuron G. Neurons B and F show no Cal'. increase in response to t-ACPD, although they both respond to 100 FM NMDA. Part of the increase in Ca2+ upon removal of Mgz+ from the buffer may be from release of transmitter glutamate from neurons in the culture dish. This would tend to increase intracellular Ca*+ via the unblocked NMDA receptor, as reported previously (van den Pol and Trombley, 1993) . In the same dish as neurons A-C, astrocytes D and E respond to t-ACPD, but not to NMDA. Similarly, when the order of perfusion is reversed, astrocytes H and I in the same dish as neurons F and G do not respond to NMDA, but do respond to t-ACPD. Astrocyte I shows the start of an oscillation, and astrocyte H shows a peak that decreases over about 35 sec. prandi et al., 1992) and to increase excitotoxicity in the striatum Pol and Dudek, 1993) . That this is a glutamatergic pathway is (McDonald and Schoepp, 1992 (Cahill and Menaker, 1989; Kim and Dudek, 1992) . That the mGluR 1 immunoreactivity we find in the SCN in the present study represents functional metabotropic receptors is confirmed by confocal laser Ca2+ imaging studies on cultured developing SCN neurons (Bina et al., 1993) . Because glutamate may be an important transmitter inducing phase changes in the circadian clock, the glutamate receptors postsynaptic to the retinal input would therefore play an important role in long-term changes in circadian clock function. The contribution of the glutamate metabotropic receptor to phase alterations induced by release of retinal glutamate has not yet been examined. Neuroendocrine neurons in the paraventricular and supraoptic nuclei project to the neurohypophysis and release oxytocin and vasopressin, and those in the arcuate nucleus release pituitary tropins in the median eminence. Glutamate may be released as a primary excitatory transmitter in afferent projections to these neurosecretory neurons, and the predominant type of ionotropic glutamate receptor appeared to be non-NMDA receptors (Gribkoff and Dudek, 1990; van den Pol et al., 1990; Wuarin and Dudek, 199 l) , although NMDA receptors are also expressed by these cells (Gribkoff, 199 1; Hu and Bourque, 1992; van den Pol et al., 1994) . In contrast, we find little mGluR1 expression in neuroendocrine cells in the present report. Although a few scattered cells can be found near the magnocellular neurosecretory systems, the number of immunoreactive neurons is smaller than in other regions of the hypothalamus, suggesting a negligible contribution of mGluR1 to the glutamate response of neuroendocrine neurons. On the other hand, in regions of the paraventricular nucleus that have been shown to project not to the pituitary but instead to the midbrain and spinal cord (Armstrong et al., 1980; Swanson and Kuypers, 1980 ) cells do express mGluR 1. This indicates a significant difference probably exists in the response to glutamate between neurosecretory neurons (that project to the hypophysis) and non-neurosecretory neurons (that project to other regions of the CNS).
Developmental changes
As early as El 8 we found evidence that mGluR1 RNA was expressed by hypothalamic neurons, and that this expression was much greater by P 1. In Western blots, protein was difficult to detect before Pl. However, at Pl mGluR1 protein was detected as a strong protein band; in parallel studies stained individual cells could be seen with immunocytochemistry. That the receptor was functionally active in immature hypothalamic neurons is supported by the series of physiological experiments; digital CaZ+ imaging indicated that cells cultured from El 8 embryos and allowed to recover for 3 d responded to both the nonspecific metabotropic receptor agonist quisqualate and to the more selective agonist t-ACPD. The Ca*+ rise seen with activation of the metabotropic receptor shows the receptor is functionally coupled to its second messenger effector mechanism even at early stages of neuronal development. This is at a time when immunostaining with mGluR1 antiserum of neurons in vivo or in vitro demonstrates a lack of the punctate staining characteristic of synaptic specialization seen in mature immunoreactive neurons.
That cells showed a cytoplasmic increase in Ca2+ in the absence of extracellular Ca2+ lends further credence to the specific activation of a receptor that stimulates release of Ca*+ from intracellular stores. Three days of neuronal growth in culture Neurons grown in vitro showed a developmental sequence of staining similar to that found in vivo. However, in vitro developmental expression of the punctate densities appeared retarded compared with their appearance in vivo. Ifthe punctate densities on dendrites are related to synaptic junctions, then the slower development of immunoreactivity in these subcellular regions is probably due to the small number of afferent axons innervating the neurons in culture. The functional expression of mGluR1 precedes the primary course of hypothalamic synaptogenesis. Although the amounts of protein and RNA coding for mGluR1 were at low levels in the embryonic brain, the Ca2+ imaging experiments showed that some neurons did express functional metabotropic receptors at early ages, at a time when the receptor was not clustered at possible synaptic junctions, as shown by immunocytochemistry. In parallel, a large number of hypothalamic astrocytes showed physiological responses indicative of the presence of the metabotropic receptor. With immunocytochemistry, all the strongly labeled cells studied in hypothalamic sections had the morphology of neurons, similar to other parts of the brain (Martin et al., 1992) . It is probable that the functional metabotropic receptor expressed by astrocytes as detected with Ca2+ imaging, and possibly some of the metabotropic response seen in neurons, may be due to a metabotropic receptor other than mGluR 1. A number of other metabotropic receptors have been cloned (Abe et al., 1992; Tanabe et al., 1992) , and at least one, mGluR5, has physiological properties similar to mGluR 1 (Nakanishi, 1992) . Astrocytes in some regions of the brain have been reported to express mGluR5 (Abe et al., 1992) . Alternatively, a small number of mGluR1 receptors may not be detected with protein blots, particularly if expressed by only a small number of cells, but may still underlie physiological responses to glutamate.
A number of previous reports have suggested that neurons in some regions of the brain show a stronger phosphotidylinositol response to glutamate during development than in the mature brain (Palmer et al., 1990; Sortino et al., 199 1) . Our results with Western blots suggest that at least part of this decrement in response is due to a reduction in mGluR1 protein in the adult brain. Interestingly, our developmental Northern blots do not show such a dramatically decreased RNA expression in either total brain or in the hypothalamus. These data suggest that mGluR1 RNA levels may not necessarily predict protein expression, and that brain-region-specific regulatory mechanisms may be operating at the translational level. The results found in the hypothalamus could reflect either a decreased level of translation, or accelerated degradation of mGluR1 protein in the adult compared with the P9 stage. There is evidence that receptors involved in G protein signaling, such as the metabotropic receptors, may have a rapid turnover (Bessho et al., 1993) pointing to protein degradation rate as an important regulatory mechanism. The relative reduction in hypothalamic protein and the absence of such a reduction in cerebellar protein and RNA in our studies are consistent with earlier studies that found a developmentally regulated reduction of physiological response of metabotropic receptors in the former area, and little reduction in the cerebellum (Balduini et al., 199 1; but see Palmer et al., 1990) . In addition to the reduction of protein as described in the present report, other mechanisms related to coupling of the metabotropic receptor with G proteins, or possible interactions of the metabotropic receptor with developing ionotropic glutamate receptors, may also contribute to the developmental decrease in metabotropic receptor activity. In contrast, some G protein-coupled receptors may become more active in adults, as suggested for the muscarinic receptor in cortex (Heacock et al., 1987) .
These data underscore the differential regulation of the same glutamate receptor subtype by neurons from different brain regions. Part of the increase in mGluR1 in the cerebellum may be due to the late (P7) final mitosis and migration of granule cells in the cerebellum. Granule cells, although small, constitute a very large number of cells, and they develop much later than cells of the hypothalamus. The granule cells also provide the major excitatory input to the Purkinje cells that express high levels of mGluR 1. The increase in mGluR 1 expression found in whole brain of adults relative to neonatal animals is in part due to the very strong expression of mGluR 1 in the cerebellum.
In contrast to the reduction in protein found with mGluR1 antibody staining of Western blots in adult hypothalamus, there are still a large number of cells in the adult hypothalamus that show immunoreactivity with the same antibodies. This suggests that despite the general decrease in total mGluR1 protein relative to RNA in the hypothalamus, protein is still expressed by some hypothalamic neurons. The immunostaining on individual cells studied microscopically does not appear less on adult cells than it does on neonatal cells, although quantitative evaluations based on immunostaining are difficult to make.
Together these data underline the complexities of developmental regulation of a single metabotropic glutamate receptor. The other metabotropic receptors may show similar complex profiles in their regulation in different regions ofthe brain. Given the temporal and spatial complexities of receptor expression and the interactions with other glutamate receptors, understanding the role of mGluR1 in early neuronal development will require a great deal of further examination.
